Skip to main content

XWELL, Inc. (XWEL) Stock

XWELL, Inc. Stock Details, Movements and Public Alerts

Stock Details

XWELL, Inc. (XWEL), a prominent company in the healthcare sector within the diagnostics & research industry, is based in United States and primarily trades on the NCM.Currently, the stock is trading at $1.40. Over the past 52 weeks, it has ranged between $0.26 and $2.20. This places the current price at 63.6% of its 52-week high and 438.5% above its 52-week low. 0The 14-day Relative Strength Index (RSI) stands at 62.64, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $0.68 by 105.88%. Similarly, it is above its 200-day moving average of $0.89 by 57.30%. The MACD histogram is 0.01, indicating bullish momentum (MACD Line: 0.26, Signal Line: 0.25). There is currently 1 active alert set for XWEL by users.

52-Week Range

$2.20 - $0.26

-36.36% from high · +438.46% from low

Avg Daily Volume

24,726,083

20-day average

100-day avg: 5,280,470

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

-0.53

EV/EBITDA

-2.51

EPS (TTM)

-$2.96

Price to Sales

0.27

Beta

0.86

Less volatile than market

Q:How is XWEL valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is XWEL's risk profile compared to the market?
With a beta of 0.86, XWELL, Inc. is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability.

Performance & Growth

Profit Margin

-51.85%

Operating Margin

-3.84%

EBITDA

$-9,209,000

Return on Equity

-158.99%

Return on Assets

-22.55%

Revenue Growth (YoY)

-12.80%

Q:How profitable and efficient is XWEL's business model?
XWELL, Inc. achieves a profit margin of -51.85%, meaning it retains $-51.85 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of -3.84% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -158.99% and ROA at -22.55%, the company achieves moderate returns on invested capital.
Q:What are XWEL's recent growth trends?
XWELL, Inc.'s revenue declined by 12.80% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions. These growth metrics should be evaluated against Diagnostics & Research industry averages for proper context.

Company Size & Market

Market Cap

$8.1M

Revenue (TTM)

$29.52M

Revenue/Share (TTM)

$5.44

Shares Outstanding

5.77M

Book Value/Share

-$1.10

Asset Type

EQUITY

Q:What is XWEL's market capitalization and position?
XWELL, Inc. has a market capitalization of $8.1M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 5.77M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Diagnostics & Research industry, it competes with other firms in this sector.
Q:How does XWEL's price compare to its book value?
XWELL, Inc.'s book value per share is -$1.10, while the current stock price is $1.40, resulting in a price-to-book (P/B) ratio of -1.28. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As EQUITY, this represents a specific type of security.

Fundamentals last updated: Mar 17, 2026, 02:13 AM

Technical Indicators

RSI (14-day)

62.64

Neutral

50-Day Moving Average

$0.68

105.88% above MA-50

200-Day Moving Average

$0.89

57.30% above MA-200

MACD Line

0.26

MACD Signal

0.25

MACD Histogram

0.01

Bullish

Q:What does XWEL's RSI value tell investors?
The RSI (Relative Strength Index) for XWEL is currently 62.64, indicating the stock is showing bullish momentum (60-70 range). The stock has positive momentum without being extremely overbought. This zone often occurs during healthy uptrends where buyers remain in control. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
Q:How should traders interpret XWEL's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.26 above the signal line at 0.25, with histogram at 0.01. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($0.68) is below the 200-day MA ($0.89), forming a death cross pattern that often warns of extended weakness. Price is currently above both MAs, confirming strength.

Indicators last updated: Mar 17, 2026, 12:39 AM

Active Alerts

Alert Condition
Price rises above
Threshold
$1.60
Created
Mar 11, 2026, 05:19 PM

Stay Ahead of the Market with XWELL, Inc. Alerts

Set up price alerts for XWELL, Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.